From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease

Documenti analoghi

• Repurposing an Antifungal Drug as an Effective Insulin Aggregation Inhibitor
  di: Anirban Das, et al.
  Pubblicazione: (2026)
• Licochalcone A as Novel Multitarget Inhibitors via AChE, BuChE, and Synapsin III for Therapeutic Intervention Against Alzheimer’s Disease: Computer‐Aided Drug Design
  di: Ali Alimari, et al.
  Pubblicazione: (2026)
• Molecular Insights Into Repurposed Drug Interactions With HDAC11 for Advancing Epigenetic Therapeutics in Cancer and Neurodegenerative Diseases
  di: Yinsheng Yang, et al.
  Pubblicazione: (2026)
• Repurposing of FDA‐Approved Drugs as Acetylcholinesterase Inhibitors for Alzheimer's Disease: A Combined In Silico and In Vitro Evaluation and Structure–Activity Relationship
  di: Merve Sıkık, et al.
  Pubblicazione: (2025)
• A Repurposing Pipeline to Candidate‐Suitable Inhibitors of Tyrosinase: Computational and Bioassay Studies
  di: Maryam Kabiri, et al.
  Pubblicazione: (2024)